Producing Cannabinoids From Sources Beyond Cannabis

Posted on by

Producing cannabinoids from sources beyond cannabis with Adam Carlson, Head of Life Sciences at AltaCorp Capital Inc. Canadian investment bank AltaCorp Capital has published a research report explaining options for producing cannabinoids from sources beyond cannabis. Analyst and Managing Director David Kideckel, Ph.D., explained in “Synthetically-Derived Cannabinoids: The Next Generation of Cannabinoid Production” that synthetic and biosynthetic cannabinoid production have the potential to disrupt the cannabis industry supply chain. He details the benefits and disadvantages of these alternative production processes relative to plant-based extraction. ATB Capital Markets provides investment banking and financial services, combining local market and industry specialization with global knowledge and an international reach. Established in 2020 through the acquisition of AltaCorp Capital, which was founded by the late George Gosbee in 2010, ATB Capital Markets helps clients succeed through their services.  Above all, they believe their clients deserve excellence. With expanded financial and advisory services offerings and a highly specialized team, they bring entrepreneurism, unique opportunities, and creative solutions. This all comes with integrity and an unwavering commitment to serve their client's best interests.